Patient Financial News

Subscribe to enjoy similar stories. Raamdeo Agrawal, co-founder of Motilal Oswal Financial Services, says the next trillion dollars of India’s market capitalization could create more wealth than the last. Drawing on decades of market cycles, the ace investor, speaking at the Mint Money Festival on 14 February in Mumbai, argued that compounding on a larger base, deeper participation and improving corporate profitability could make the coming decades disproportionately rewarding for patient investors.

Subscribe to enjoy similar stories. MUMBAI : Early-stage healthcare-focused venture capital firm W Health Ventures is looking for bolder bets with its second fund, building companies from the ground up in areas like oncology, longevity, and chronic pain management, managing partner Pankaj Jethwani told Mint in an interview. The firm on Thursday announced the initial close of its Fund II at ₹550 crore, aiming for ₹630 crore.

Subscribe to enjoy similar stories. Imagine you’re in your late 60s and are diagnosed with Alzheimer’s disease. You start planning the rest of your life: telling your spouse you may eventually become incapacitated; looking into long-term memory care; checking off as many bucket list items as you can.

Subscribe to enjoy similar stories. Across the country, India’s real estate sector is witnessing a full-blown boom, with residential prices climbing sharply in most cities. Yet, for the discerning and patient homebuyer, even amid sky-rocketing values, there is still hope.

Subscribe to enjoy similar stories. Two years ago, a GLP-1 prescription could cost an uninsured patient more than $1,000 a month. Today, Novo Nordisk’s Wegovy pill starts at just $149 through cash-pay programs.

Subscribe to enjoy similar stories. The White House on Thursday launched its drug-pricing website, dubbed TrumpRx, the culmination of efforts by the administration to bring down pharmaceutical costs for some consumers.

Subscribe to enjoy similar stories. NEW DELHI: The Union government has ordered a nationwide audit of all 4,153 licensed blood banks and centres after children in some states tested HIV-positive following allegedly contaminated transfusions, according to two government officials and a document that Mint reviewed. The Central Drugs Standard Control Organization (CDSCO) has started risk-based inspections of all blood centres and any facility not compliant with the standards will be closed down, the officials said.

Subscribe to enjoy similar stories. The Economic Survey for 2025-26, being released on 29 January, comes at an extraordinary time for the world. Global politics is in flux.

Subscribe to enjoy similar stories. India’s landmark free trade deal with the European Union, finalised on Tuesday, includes significant tariff cuts on exports of pharmaceutical products as well as optical, medical and surgical equipment from Europe to India. Tariffs on pharmaceutical exports from Europe to India will drop to zero from 11% for almost all products.

Subscribe to enjoy similar stories. The National Board of Examinations in Medical Sciences (NBEMS) last week launched its artificial intelligence (AI) training program for postgraduate medical students and faculty across all government and private medical colleges. The program, which received an overwhelming response of more than 50,000 confirmed early registrations, connects clinical knowledge with data science, preparing future healthcare leaders to effectively manage AI solutions in real-world settings.

Subscribe to enjoy similar stories. Mumbai: InvAscent-backed Ankura Hospitals has kickstarted a fundraising process to raise ₹400-500 crore in a mix of primary and secondary transactions, three people familiar with the matter said. The Hyderabad-based company has appointed Alvarez & Marsal as an advisor to facilitate the capital raise, and the deal is expected to be launched in the coming weeks, the people said.

Subscribe to enjoy similar stories. New Delhi: Neiox Eco Cycle isn’t the sort of startup you read about every day. It isn’t solving for fashion, food or grocery delivery.

Subscribe to enjoy similar stories. Earlier this month Danish drugmaker Novo Nordisk launched its oral Wegovy weight-loss pill in the US, for "needle-averse patients". The starting dose is priced at $149 a month for patients paying in cash, compared to the injectable version's list price of more than $1,300.

Subscribe to enjoy similar stories. New Delhi: Armed with a favourable Supreme Court decision, India’s tax authority plans to proceed with caution while reopening assessment against Tiger Global Management LLC’s 2018 stake sale in Flipkart Pvt., respecting the company’s right to appeal, according to two officials familiar with the matter.

Subscribe to enjoy similar stories. NEW DELHI : Amid a rising number of complaints over botched hair transplants, the Centre plans to reclassify the procedure from the ‘cosmetic salon’ category to a strictly regulated ‘surgical practice' to rein in malpractices in the $252 million industry, according to three government officials and documents reviewed by Mint.

Subscribe to enjoy similar stories. BENGALURU : Venture capital and private equity investors are increasing their bets on post-hospital care—often referred to as ‘continuum care’—as India’s hospitals are discharging patients more quickly and families seek structured recovery outside hospitals.

Subscribe to enjoy similar stories. On 7-8 January, OpenAI rolled out two healthcare products: ChatGPT Health for users and ChatGPT for Healthcare, for organizations in the industry. While ChatGPT Health is an extension of the existing chatbot, offering a space dedicated for health, the latter aims to automate workflows for healthcare organizations, a niche where Indian healthtech firms have attracted investor interest.

₹3,500–4,000 crore with existing investor Lighthouse Funds and the promoters set to offload a total of about 60% of their holding,” one of the people cited above said. A second person confirmed the details, adding that this will largely be a secondary transaction.This assumes significance as fast-growing, consumer-facing healthcare companies are attracting strong investor interest, backed by rising insurance penetration, improving affordability and a widening patient base in India’s medical devices sector.In August, Mint first reported that the company had reopened talks and appointed O3 Capital to help with the mandate after discussions with Temasek for a significant minority stake were put on hold in 2024.Tynor’s founder Pushvinder Jit Singh, Lighthouse Funds, Kedaara and O3 Capital did not respond to emails sent on Tuesday.In 2024, Mint had exclusively reported that Singapore-based Temasek was the front-runner to acquire a significant minority stake in the company, outpacing other global private equity firms such as Warburg Pincus and Norwest Venture Partners.The new development comes nearly eight years after Tynor raised $21 million at a post-money valuation of $103.3 million from investors including Lighthouse, Thuasne and Vihome B.V.

pharmaceutical sector, a major global supplier of generic medicines.The revised Schedule M GMP had been earlier extended from the previous 1 January 2025 cutoff. The proposed extension for MSMEs, which have revenue of ₹250 crore or less, comes in the backdrop of less than a third of them submitting their upgrade plans, with the remaining units risking immediate closure and penalties.There are a total of 10,500 drug manufacturing units in India, of which 8,500 fall under the MSME category.

New Delhi: To reduce India’s high burn-related mortality rates and standardise care across hospitals, the Centre has issued comprehensive treatment guidelines that formalise first-aid practices and discourage the use of common household remedies, according to two officials and a document seen by Mint.The development assumes significance given the rising burn injuries—an estimated 6-7 million injuries annually and around 150,000 deaths each year—with women and children disproportionately affected due to cooking fires and flammable liquids.The new framework, to be adopted by health centres with immediate effect, seeks to replace India’s fragmented, hospital-specific burn care protocols with a uniform, evidence-based system ranging from first responders, primary health centres (PHCs) and tertiary hospitals.The guidelines organise burn care into four levels—pre-hospital, primary, secondary and tertiary—clearly outlining responsibilities at each stage to reduce delays, inappropriate treatment and avoidable complications.They address a critical gap where healthcare professionals often relied on a mix of personal expertise and conflicting protocols due to resource constraints.The effectiveness of burn care in India has been constrained by chronic shortages of trained personnel, essential supplies and specialised equipment, gaps that are most acute in resource-limited settings, impacting patient recovery and complication rates."Standard treatment guidelines are vital because medical science is evidence-based, yet currently, individual hospitals often follow disparate protocols. It is crucial to collate best practices to ensure uniformity," said Dr.

Subscribe to enjoy similar stories. NEW DELHI : Obtaining informed consent, usage-based billing, and the public display of charges are among the Centre’s latest guidelines to regulate the use of high-cost ventilators in private hospitals.